Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #388570 on Innovation Pharmaceuticals Inc (IPIX)
loanranger
03/05/22 8:24 PM
#388571 RE: williamssc #388570
Lemoncat
03/05/22 10:27 PM
#388573 RE: williamssc #388570
JTORENCE
03/05/22 11:19 PM
#388575 RE: williamssc #388570
sox040713
03/07/22 1:29 AM
#388603 RE: williamssc #388570
We remain eager to learn about Brilacidin’s treatment effect in COVID-19 patients, a possible gateway indication toward evaluating Brilacidin in other acutely infectious viral diseases, building on the type of promising pre-clinical data presented at ASV 2021 by GMU scientists. Two independent Machine Learning studies identified Brilacidin as one of the most promising inhibitors of SARS-CoV-2, the virus responsible for COVID-19, based on Brilacidin’s molecular properties. https://www.ipharminc.com/press-release/2021/7/22/innovation-pharmaceuticals-announces-new-in-vitro-data-supporting-brilacidins-broad-spectrum-antiviral-potential-presented-at-the-american-society-of-virologys-annual-meeting
I rather like this quote: "Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned"